Moreover, the natural product, Saikosaponin D (SSD), attenuates EAE symptom by inhibiting OPTN expression, suggesting that interfering OPTN could be beneficial for the therapeutic treatment of autoimmune diseases. The gene discussed is OPTN; the disease is autoimmune disease.